Ligand validation:2UYH

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 2UYH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2UYH_SAH_A_1328	79%	15%	0.127	0.972	1.31	2.45	4	4	0	0	100%	1
2Z6U_SAH_A_328	74%	12%	0.134	0.966	1.75	2.33	4	8	0	0	100%	1
5CIY_SAH_A_401	74%	31%	0.094	0.924	1.14	1.58	2	3	0	0	100%	1
2Z6Q_SAH_A_328	73%	12%	0.134	0.96	1.75	2.27	4	8	1	0	100%	1
2UYC_SAH_A_1328	70%	15%	0.125	0.942	1.37	2.36	5	4	0	0	100%	1
2HR1_SAH_A_328	67%	14%	0.119	0.928	2.17	1.7	5	6	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
6U8W_SAH_A_901	100%	22%	0.028	0.995	1.23	1.96	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.